<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Merck Stokes M&amp;A Fires with $41.1 Billion Bid for Schering-Plough</title>
	<atom:link href="http://www.moneymorning.com/2009/03/09/merck-stokes-ma-fires/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.moneymorning.com/2009/03/09/merck-stokes-ma-fires/</link>
	<description>Investment News Provider</description>
	<lastBuildDate>Thu, 19 Nov 2009 15:36:16 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: After a Tough First Quarter, Investors Have Cause For Cautious Optimism</title>
		<link>http://www.moneymorning.com/2009/03/09/merck-stokes-ma-fires/comment-page-1/#comment-19880</link>
		<dc:creator>After a Tough First Quarter, Investors Have Cause For Cautious Optimism</dc:creator>
		<pubDate>Tue, 14 Apr 2009 10:08:05 +0000</pubDate>
		<guid isPermaLink="false">http://www.moneymorning.com/?p=5671#comment-19880</guid>
		<description>[...] Money Morning News Analysis: Merck Stokes M&amp;A Fires with $41.1 Billion Bid for Schering-Plough. [...]</description>
		<content:encoded><![CDATA[<p>[...] Money Morning News Analysis: Merck Stokes M&#38;A Fires with $41.1 Billion Bid for Schering-Plough. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Biotech Churns Out Big Returns in Bull and Bear Markets</title>
		<link>http://www.moneymorning.com/2009/03/09/merck-stokes-ma-fires/comment-page-1/#comment-19298</link>
		<dc:creator>Biotech Churns Out Big Returns in Bull and Bear Markets</dc:creator>
		<pubDate>Mon, 06 Apr 2009 09:55:54 +0000</pubDate>
		<guid isPermaLink="false">http://www.moneymorning.com/?p=5671#comment-19298</guid>
		<description>[...] Money Morning:  Merck Stokes M&amp;A Fires with $41.1 Billion Bid for Schering-Plough [...]</description>
		<content:encoded><![CDATA[<p>[...] Money Morning:  Merck Stokes M&amp;A Fires with $41.1 Billion Bid for Schering-Plough [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Deepanvith</title>
		<link>http://www.moneymorning.com/2009/03/09/merck-stokes-ma-fires/comment-page-1/#comment-18459</link>
		<dc:creator>Deepanvith</dc:creator>
		<pubDate>Wed, 25 Mar 2009 16:16:07 +0000</pubDate>
		<guid isPermaLink="false">http://www.moneymorning.com/?p=5671#comment-18459</guid>
		<description>i love merck</description>
		<content:encoded><![CDATA[<p>i love merck</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Roche Strikes $46.8 Billion Deal for Genentech &#124; Jutia Group</title>
		<link>http://www.moneymorning.com/2009/03/09/merck-stokes-ma-fires/comment-page-1/#comment-17660</link>
		<dc:creator>Roche Strikes $46.8 Billion Deal for Genentech &#124; Jutia Group</dc:creator>
		<pubDate>Fri, 13 Mar 2009 14:08:39 +0000</pubDate>
		<guid isPermaLink="false">http://www.moneymorning.com/?p=5671#comment-17660</guid>
		<description>[...] deal marks the third mega-deal among large pharmaceutical companies this year &#8212; and the second this week &#8211; as large drug firms struggle with a long line of blockbuster drugs coming off patent, stiff [...]</description>
		<content:encoded><![CDATA[<p>[...] deal marks the third mega-deal among large pharmaceutical companies this year &mdash; and the second this week &ndash; as large drug firms struggle with a long line of blockbuster drugs coming off patent, stiff [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Roche Keeps M&#38;A Party Rolling with $46.8 Billion Deal for Genentech</title>
		<link>http://www.moneymorning.com/2009/03/09/merck-stokes-ma-fires/comment-page-1/#comment-17646</link>
		<dc:creator>Roche Keeps M&#38;A Party Rolling with $46.8 Billion Deal for Genentech</dc:creator>
		<pubDate>Fri, 13 Mar 2009 09:24:49 +0000</pubDate>
		<guid isPermaLink="false">http://www.moneymorning.com/?p=5671#comment-17646</guid>
		<description>[...] deal marks the third mega-deal among large pharmaceutical companies this year &#8212; and the second this week &#8211; as large drug firms struggle with a long line of blockbuster drugs coming off patent, stiff [...]</description>
		<content:encoded><![CDATA[<p>[...] deal marks the third mega-deal among large pharmaceutical companies this year &mdash; and the second this week &ndash; as large drug firms struggle with a long line of blockbuster drugs coming off patent, stiff [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
